Themis Medicare Q1 PAT at Rs 28.74 cr on share sale gain, new CS appointed
THEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Themis Medicare Q1 FY27 standalone PAT came in at Rs 28.74 cr vs a loss of Rs 15.37 cr last year, boosted by a one-time Rs 99.67 cr gain from selling shares in associate Gujarat Themis Biosyn for Rs 100 cr. Underlying core business pre-tax loss widened to Rs 56.94 cr from Rs 13.92 cr. Revenue declined to Rs 86.96 cr from Rs 97.58 cr. Consolidated PAT was Rs 24.61 cr vs a loss of Rs 14.22 cr. Board accepted Nagraj Mogaveera's resignation as interim Company Secretary and appointed Suresh Savaliya (CS with 23 years experience at Reliance and Essel Group) as new Company Secretary effective 13 Aug 2026.
PAT swing is from a one-time share sale gain, not core operations. Underlying losses widened. New CS brings strong listed-company compliance experience.